Kodiak Sciences stock soars on positive AMD trial data
Investing.com — Kodiak Sciences Inc (NASDAQ:KOD) shares surged as much as 90% in premarket trading Monday following positive…
MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease
MannKind MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation…